Claros Technologies Expands Business to Europe with Pharmaceutical Production

Claros Technologies Expands into Europe



Claros Technologies, a global leader in permanent PFAS (per- and polyfluoroalkyl substances) destruction technology, has recently made significant strides in its business operations. The company announced its expansion into Europe and its entry into pharmaceutical manufacturing after successful pilot testing with its ClarosTechUV™ system at Bachem AG's facility in Bubendorf, Switzerland. Bachem, recognized as a leading manufacturer of peptide and oligonucleotide active pharmaceutical ingredients (APIs), has been imperative in this pilot project which effectively demonstrated the capabilities of the ClarosTechUV™ system under real production conditions.

In the pilot program, ClarosTechUV™ met or surpassed the performance targets set by Bachem for trifluroacetic acid (TFA), addressing one of the significant environmental challenges in the pharmaceutical industry today.

The Importance of PFAS Destruction in Pharma


As the pharmaceutical industry rapidly grows, the need for responsible handling of the waste generated during production increases. Bachem's proactive usage of ClarosTechUV™ technology underscores their leadership in operational excellence and environmental stewardship. This collaboration not only enhances the efficiency of pharmaceutical manufacturing but also aligns with evolving global regulations regarding harmful substances like TFA.

According to Michelle Bellanca, the CEO and co-founder of Claros Technologies, this partnership signifies a major advancement in both Claros’ journey and the pharmaceutical industry. With the increasing production of peptide therapeutics and GLP-1 medications, the industry is facing a pressing challenge regarding the management of ultrashort-chain PFAS in industrial wastewater.

Groundbreaking Results from the Pilot Project


The pilot project at Bachem revealed that, post-treatment with the ClarosTechUV™ system, residual concentrations of TFA were remarkably low, demonstrating the effectiveness of the technology in ensuring sustainable pharmaceutical production. This finding was corroborated by Patrick Barth, head of corporate communications at Bachem, who noted the significant reduction in TFA levels.

André Casagrande, the site manager at Bachem’s Bubendorf campus, articulated the importance of integrating innovation with environmental responsibility, stating, "We want to not only help people through our products but also play a responsible role in regard to the environment."

A Sustainable Future with ClarosTechUV™


Designed specifically for high-flow industrial applications, the ClarosTechUV™ system offers a cutting-edge solution for the permanent destruction of PFAS at the source. Unlike traditional treatment methods that separate PFAS into secondary waste streams, which require ongoing disposal, the Claros technology eliminates PFAS completely and sustainably. This advance not only meets the operational needs of pharmaceutical manufacturers but also paves the way for a more environmentally responsible future.

Bachem's coordination with Claros Technologies presents a strategic model for other companies in the pharmaceutical sector as it grapples with stringent regulations regarding hazardous waste.

As regulatory frameworks continue to evolve, particularly in Europe and the U.S., the collaboration illustrates how innovation can drive compliance while ensuring the responsible manufacture of essential medicines necessary for global health management.

Claros Technologies, established in 2018 and headquartered in Minneapolis, focuses on solutions aimed at eliminating forever chemicals from various environments including industrial wastewater and groundwater. The ClarosTech™ and ClarosLabs™ divisions specialize in the destruction and analysis of PFAS, reflecting the company's commitment to tackling one of the most urgent environmental issues of our time.

For more information on how Claros Technologies is at the forefront of this critical environmental challenge, visit their website and stay updated on their progress towards a sustainable future in chemical management.

Topics General Business)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.